Adcock Ingram Pharma Private Limited, a active private limited company, was established on 07 June 2021 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299KA2021PTC148184. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹71.46 Cr and a paid-up capital of ₹71.46 Cr.
It upholds a compliant status. Employing 67 professional, Its leadership includes Pravin Vaidyanathan Iyer (Director), Pankaj Garg (Director), Yasuhiro Nakagiri (Director). Past directors included Gundala Ramireddy, Pravin Vaidyanathan Iyer, Pankaj Garg. It holds ₹58.00 Cr open charges and no settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 41/42, Bommasandra Industrial Area Anekal Taluk, Bengaluru, Karnataka, 560099.
U24299KA2021PTC148184
148184
07 June 2021
₹71.46 Cr
₹71.46 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Adcock Ingram Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pravin Vaidyanathan Iyer | Director | 07 Jun 2021 | Current |
| Pankaj Garg | Director | 07 Jun 2021 | Current |
| Yasuhiro Nakagiri | Director | 08 May 2024 | Current |
| Ammanna Chowdary Yarlagadda | Managing Director | 21 Sep 2022 | Current |
| Yudhveer Singh | Director | 24 Jan 2022 | Current |
| Kenshi Murase | Director | 11 Jun 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 28 Mar 2022 | Past |
| Pramod Abcsdd | Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Director | 27 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
| Pramod Abcsdd | Director | 12 Feb 2025 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adcock Ingram Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 88.45% decrease. The company also saw a substantial fall in profitability, with a 344.67% decrease in profit. The company's net worth Soared by an impressive increase of 107.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adcock Ingram Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹580,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2022 | Others | ₹58.00 Cr | Open |
Explore comprehensive loan charge details -
Adcock Ingram Pharma has a workforce of 67 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adcock Ingram Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adcock Ingram Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dorette Neethling was appointed as a Additional Director was appointed as a Additional Director on 19 Feb 2025 & has been associated with this company since 9 months 11 days . was completed.
A charge with Others of Rs. 58.00 Cr registered on 08 Mar 2022 with Charge ID 100553591 was modified on 30 Dec 2024. was recorded as a recent event.
Adcock Ingram Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Yasuhiro Nakagiri was appointed as a Director was appointed as a Director on 08 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Progress on Adcock Ingram Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on Chandra Mohan was appointed as a CFO was appointed as a CFO on 02 Aug 2023 & has been associated with this company since 2 years 4 months . was documented.
The CIN of Adcock Ingram Pharma Private Limited is U24299KA2021PTC148184.
Adcock Ingram Pharma Private Limited is headquartered at 41/42, Bommasandra Industrial Area Anekal Taluk, Bengaluru, Karnataka, 560099.
Adcock Ingram Pharma Private Limited was incorporated on 07 June 2021.
The current directors of Adcock Ingram Pharma Private Limited are
The primary industry of Adcock Ingram Pharma Private Limited is Manufacturing.
Adcock Ingram Pharma Private Limited is unlisted.
The authorized capital of Adcock Ingram Pharma Private Limited is ₹71.46 Cr, and the paid-up capital is ₹71.46 Cr.
The compliance status of Adcock Ingram Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX